BusinessAlectos Therapeutics Announces FDA Orphan Drug Designation for MK-8719: An Investigational Small-molecule OGA Inhibitor for Treatment of Progressive Supranuclear PalsyBy Nasdaq OMXApr 20, 2016, 1:00 PM UTC
BusinessAgile Therapeutics to Present at Women’s Health 2016: The 24th Annual CongressBy Nasdaq OMXApr 15, 2016, 12:00 PM UTC
BusinessAbCellera and Merck Sign Novel Therapeutic Antibody Discovery CollaborationBy Nasdaq OMXJan 27, 2016, 9:08 PM UTC
